» Articles » PMID: 35564416

Awareness of Chronic Kidney Disease, Medication, and Laboratory Investigation Among Nephrology and Urology Patients of Quetta, Pakistan

Overview
Publisher MDPI
Date 2022 May 14
PMID 35564416
Authors
Affiliations
Soon will be listed here.
Abstract

Patients’ awareness is critical in medical care, as it can serve as an input into the adjustment of interventions. The aim of study was to explore the level of awareness regarding chronic kidney disease (CKD), its medications, and laboratory investigations among nephrology and urology patients of Quetta. The cross-sectional study was used by adopting and culturally modifying a questionnaire. By convenient sampling technique, a total of 500 questionnaires were self-administered to inpatients, outpatients, and dialysis patients, and 468 responses (response rate 93.6%) were analyzed. Descriptive statistics, inferential statistics, and reliability analysis were performed on SPSS v25. A majority, 50.3% (n = 235), was unaware of symptoms that will develop due to worsening of disease, while 56.2% (n = 263) were unaware of what aggravates their kidney function. Almost half of the affected individuals, 47.4% (n = 222), have no understanding about the long-term prognosis of the disease. The majority of the respondents, 51.5% (n = 248), do not know about the names and usage of medications, and 62.4% (n = 292) were unaware of the medicines that may impair kidney function; more than half, 66.7% (n = 312), were unaware about the necessary laboratory investigations. A strong association between awareness and patient education level was found (p < 0.001). Awareness regarding disease condition, medications, and laboratory investigations of CKD among nephrology and urology patients of Quetta was found out to be low, which needs immediate educational intervention.

Citing Articles

Acute and sub-acute toxicity study of aqueous and methanol root extract of in male albino rats.

Ainyanbhor I, Onoagbe I, Edo G, Yousif E, Akpoghelie P, Owheruo J Toxicol Rep. 2024; 13:101786.

PMID: 39526239 PMC: 11543917. DOI: 10.1016/j.toxrep.2024.101786.


Molecular Mechanisms of Oxidative Stress in Acute Kidney Injury: Targeting the Loci by Resveratrol.

Rashid H, Jali A, Akhter M, Abdi S Int J Mol Sci. 2024; 25(1).

PMID: 38203174 PMC: 10779152. DOI: 10.3390/ijms25010003.


Knowledge, attitude and perceptions of pharmacists regarding renal dose adjustment among chronic kidney disease patients in Pakistan.

Zafar R, Rehman I, Shah Y, Ali Z, Ming L, Khan T J Pharm Policy Pract. 2023; 16(1):102.

PMID: 37726861 PMC: 10507879. DOI: 10.1186/s40545-023-00606-4.


Dialysis Decision Making and the Patient Experience: Lessons From Pakistan.

Rizzolo K, Al-Rousan T, Cervantes L Kidney Med. 2022; 4(11):100556.

PMID: 36353649 PMC: 9637990. DOI: 10.1016/j.xkme.2022.100556.

References
1.
Tillyard G, DeGennaro Jr V . New Methodologies for Global Health Research: Improving the Knowledge, Attitude, and Practice Survey Model Through Participatory Research in Haiti. Qual Health Res. 2018; 29(9):1277-1286. DOI: 10.1177/1049732318816675. View

2.
Lowe N, Westaway E, Munir A, Tahir S, Dykes F, Lhussier M . Increasing Awareness and Use of Iodised Salt in a Marginalised Community Setting in North-West Pakistan. Nutrients. 2015; 7(11):9672-82. PMC: 4663618. DOI: 10.3390/nu7115490. View

3.
Arjuna Rao A, Phaneendra D, Pavani C, Soundararajan P, Rani N, Thennarasu P . Usage of complementary and alternative medicine among patients with chronic kidney disease on maintenance hemodialysis. J Pharm Bioallied Sci. 2016; 8(1):52-7. PMC: 4766780. DOI: 10.4103/0975-7406.171692. View

4.
Jha V . Herbal medicines and chronic kidney disease. Nephrology (Carlton). 2010; 15 Suppl 2:10-7. DOI: 10.1111/j.1440-1797.2010.01305.x. View

5.
Stevens L, Fares G, Fleming J, Martin D, Murthy K, Qiu J . Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005; 16(8):2439-48. DOI: 10.1681/ASN.2005020192. View